Health management program: factors influencing completion of therapy with high-dose interferon alfa-2b for high-risk melanoma.
about
Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study.Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study.Defining the palliative care patient: a systematic review.Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.Mental health services use by melanoma patients receiving adjuvant interferon: association of pre-treatment mental health care with early discontinuation.Serum TNF-α, B2M and sIL-2R levels are biological correlates of outcome in adjuvant IFN-α2b treatment of patients with melanoma.
P2860
Health management program: factors influencing completion of therapy with high-dose interferon alfa-2b for high-risk melanoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Health management program: fac ...... lfa-2b for high-risk melanoma.
@ast
Health management program: fac ...... lfa-2b for high-risk melanoma.
@en
type
label
Health management program: fac ...... lfa-2b for high-risk melanoma.
@ast
Health management program: fac ...... lfa-2b for high-risk melanoma.
@en
prefLabel
Health management program: fac ...... lfa-2b for high-risk melanoma.
@ast
Health management program: fac ...... lfa-2b for high-risk melanoma.
@en
P2093
P2860
P356
P1433
P1476
Health management program: fac ...... lfa-2b for high-risk melanoma.
@en
P2093
D Macdonald
J F Pouliot
K Mitchinson
N Levesque
P2860
P356
10.3747/CO.2008.200
P577
2008-01-01T00:00:00Z